124 related articles for article (PubMed ID: 18579687)
1. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.
Turner DP; Findlay VJ; Kirven AD; Moussa O; Watson DK
Mol Biol Cell; 2008 Sep; 19(9):3745-57. PubMed ID: 18579687
[TBL] [Abstract][Full Text] [Related]
2. Mechanical compression drives cancer cells toward invasive phenotype.
Tse JM; Cheng G; Tyrrell JA; Wilcox-Adelman SA; Boucher Y; Jain RK; Munn LL
Proc Natl Acad Sci U S A; 2012 Jan; 109(3):911-6. PubMed ID: 22203958
[TBL] [Abstract][Full Text] [Related]
3. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
[TBL] [Abstract][Full Text] [Related]
4. Master regulators of FGFR2 signalling and breast cancer risk.
Fletcher MN; Castro MA; Wang X; de Santiago I; O'Reilly M; Chin SF; Rueda OM; Caldas C; Ponder BA; Markowetz F; Meyer KB
Nat Commun; 2013; 4():2464. PubMed ID: 24043118
[TBL] [Abstract][Full Text] [Related]
5. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.
Buchwalter G; Hickey MM; Cromer A; Selfors LM; Gunawardane RN; Frishman J; Jeselsohn R; Lim E; Chi D; Fu X; Schiff R; Brown M; Brugge JS
Cancer Cell; 2013 Jun; 23(6):753-67. PubMed ID: 23764000
[TBL] [Abstract][Full Text] [Related]
6. Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas.
Lee S; Osmanbeyoglu HU
Breast Cancer Res; 2022 Jul; 24(1):54. PubMed ID: 35906698
[TBL] [Abstract][Full Text] [Related]
7. Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts.
Krisanits BA; Woods P; Nogueira LM; Woolfork DD; Lloyd CE; Baldwin A; Frye CC; Peterson KD; Cosh SD; Guo QJ; Spruill LS; Lilly MB; Helke K; Li H; Hanna GS; Hamann MT; Thomas C; Ahmed M; Gooz MB; Findlay VJ; Turner DP
Transl Oncol; 2022 Mar; 17():101350. PubMed ID: 35091340
[TBL] [Abstract][Full Text] [Related]
8. Double Agent:
Ye T; Feng J; Wan X; Xie D; Liu J
Cancer Manag Res; 2020; 12():3891-3902. PubMed ID: 32547225
[TBL] [Abstract][Full Text] [Related]
9. Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.
Chen EB; Zhou SL; Pang XG; Yin D; Miao PZ; Yang Y; Chen Q; Zhu K; Gao DM; Liu TS; Wang XY; Shi YH; Wu WZ; Zhou J; Zhou ZJ; Dai Z
Oncotarget; 2017 Aug; 8(32):52488-52500. PubMed ID: 28881746
[TBL] [Abstract][Full Text] [Related]
10. Gene signature driving invasive mucinous adenocarcinoma of the lung.
Guo M; Tomoshige K; Meister M; Muley T; Fukazawa T; Tsuchiya T; Karns R; Warth A; Fink-Baldauf IM; Nagayasu T; Naomoto Y; Xu Y; Mall MA; Maeda Y
EMBO Mol Med; 2017 Apr; 9(4):462-481. PubMed ID: 28255028
[TBL] [Abstract][Full Text] [Related]
11. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
12. GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration.
Tamura RE; Paccez JD; Duncan KC; Morale MG; Simabuco FM; Dillon S; Correa RG; Gu X; Libermann TA; Zerbini LF
Oncotarget; 2016 Mar; 7(12):13865-79. PubMed ID: 26885618
[TBL] [Abstract][Full Text] [Related]
13. A systems approach to understanding human rhinovirus and influenza virus infection.
Kim TK; Bheda-Malge A; Lin Y; Sreekrishna K; Adams R; Robinson MK; Bascom CC; Tiesman JP; Isfort RJ; Gelinas R
Virology; 2015 Dec; 486():146-57. PubMed ID: 26437235
[TBL] [Abstract][Full Text] [Related]
14. HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer.
Indira Chandran V; Eppenberger-Castori S; Venkatesh T; Vine KL; Ranson M
Oncoscience; 2015; 2(3):207-24. PubMed ID: 25897424
[TBL] [Abstract][Full Text] [Related]
15. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.
Orth MF; Cazes A; Butt E; Grunewald TG
Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104
[TBL] [Abstract][Full Text] [Related]
16. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.
Scheiber MN; Watson PM; Rumboldt T; Stanley C; Wilson RC; Findlay VJ; Anderson PE; Watson DK
Neoplasia; 2014 Oct; 16(10):801-13. PubMed ID: 25379017
[TBL] [Abstract][Full Text] [Related]
17. Understanding the role of ETS-mediated gene regulation in complex biological processes.
Findlay VJ; LaRue AC; Turner DP; Watson PM; Watson DK
Adv Cancer Res; 2013; 119():1-61. PubMed ID: 23870508
[TBL] [Abstract][Full Text] [Related]
18. Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.
Mukhopadhyay A; Khoury T; Stein L; Shrikant P; Sood AK
Oncotarget; 2013 Apr; 4(4):610-21. PubMed ID: 23592399
[TBL] [Abstract][Full Text] [Related]
19. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.
Noah TK; Lo YH; Price A; Chen G; King E; Washington MK; Aronow BJ; Shroyer NF
Gastroenterology; 2013 May; 144(5):1012-1023.e6. PubMed ID: 23376423
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells.
Tang R; Kong F; Hu L; You H; Zhang P; Du W; Zheng K
Virol J; 2012 Aug; 9():163. PubMed ID: 22897902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
